Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 4Biliary Tract Neoplasms 2Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Malignant Neoplasms of Digestive Organs 1Klatskin Tumor 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Epstein-Barr Virus Infections 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1Advanced Biliary Tract Carcinoma 1

Interventions

Valganciclovir 3Rituximab 3Cisplatin 3Vincristine 2Radiotherapy, Intensity-Modulated 2Prednisone 2Matrix-M 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2pomalidomide 1dehydroftorafur 1brincidofovir 1Watchful Waiting 1Valacyclovir 1Tomography, X-Ray Computed 1Tenofovir 1Tegafur 1Taxes 1Platinum 1Phantoms, Imaging 1Paclitaxel 1Nivolumab 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mitomycin 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Interferons 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Tegafur × 1 year × Clear all
NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

National Health Research Institutes, Taiwan

Phase 3 Terminated
10 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡